P1788 Long-term treatment with rosuvastatin protects against nitrate-induced oxidative stress in the rat aorta

2003 ◽  
Vol 24 (5) ◽  
pp. 344
Author(s):  
A OTTO
1999 ◽  
Vol 126 (1) ◽  
pp. 159-168 ◽  
Author(s):  
Heidi L Andersen ◽  
Jan U Weis ◽  
Bjarne Fjalland ◽  
Niels Korsgaard

2014 ◽  
Vol 2014 ◽  
pp. 1-11 ◽  
Author(s):  
Shao-Huai Shi ◽  
Xu Zhao ◽  
Bing Liu ◽  
Huan Li ◽  
Ai-Jing Liu ◽  
...  

As a kind of medicine which can also be used as food,Alpinia oxyphyllaMiq. has a long clinical history in China. A variety of studies demonstrated the significant neuroprotective activity effects of chloroform (CF) extract from the fruits ofAlpinia oxyphylla.In order to further elucidate the possible mechanisms of CF extract which mainly contains sesquiterpenes with neuroprotection on the cognitive ability, mice were injected with Aβ1−42and later with CF in this study. The results showed that the long-term treatment of CF enhanced the cognitive performances in behavior tests, increased activities of glutathione peroxidase (GSH-px) and decreased the level of malondialdehyde (MDA), acetylcholinesterase (AChE), and amyloid-β(Aβ), and reversed the activation of microglia, degeneration of neuronal acidophilia, and nuclear condensation in the cortex and hippocampus. These results demonstrate that CF ameliorates learning and memory deficits by attenuating oxidative stress and regulating the activation of microglia and degeneration of neuronal acidophilia to reinforce cholinergic functions.


2012 ◽  
Vol 11 (3) ◽  
pp. 93-101 ◽  
Author(s):  
C. Napoli ◽  
G. Bruzzese ◽  
L. J. Ignarro ◽  
E. Crimi ◽  
F. De Nigris ◽  
...  

Aim. Sulfhydryl angiotensin-converting enzyme (ACE) inhibitors exert antiatherosclerotic effects in preclinical models and antioxidant effects in patients. However, whether ACE inhibitors have any clinically significant antiatherogenic effects remains still debated. Objectives. In mildly hypertensive patients, we evaluated the effect of the sulfhydryl ACE inhibitor zofenopril in comparison with the carboxylic ACE inhibitor enalapril on carotid atherosclerosis (intima-media thickness [IMT] and vascular lumen diameter) and systemic oxidative stress (nitrite/nitrate, asymmetrical dimethyl-L-arginine, and isoprostanes). Material and methods. In 2001, we started a small prospective randomized clinical trial on 48 newly diagnosed mildly hypertensive patients with no additional risk factors for atherosclerosis (eg, hyperlipidemia, smoke habit, familiar history of atherosclerosisrelated diseases or diabetes). Patients were randomly assigned either to the enalapril (20 mg/d, n = 24) or the zofenopril group (30 mg/d, n = 24); the planned duration of the trial was 5 years. Carotid IMT and vascular lumen diameter were determined by ultrasonography for all patients at baseline and at 1, 3, and 5 years. Furthermore, nitrite/nitrate, asymmetrical dimethyl-L-arginine, and isoprostane levels were measured. Results. In our conditions, IMT of the right and left common carotid arteries was similar at baseline in both groups (P = NS). Intima-media thickness measurements until 5 years revealed a significant reduction in the zofenopril group but not in the enalapril group (P b .05 vs enalapril-treated group). This effect was coupled with a favorable nitric oxide/oxidative stress profile in the zofenopril group. Conclusion. Long-term treatment with the sulfhydryl ACE inhibitor zofenopril besides its blood pressure–lowering effects may slow the progression of IMT of the carotid artery in newly diagnosed mildly hypertensive patients. (Am Heart J 2008;156:1154.e1-1154.e8.)


2003 ◽  
Vol 42 (3) ◽  
pp. 442-450 ◽  
Author(s):  
Uwe G??ttmann ◽  
Jens Oltersdorf ◽  
Meike Schaub ◽  
Thomas Knoll ◽  
Walter E. Back ◽  
...  

2020 ◽  
Vol 393 (12) ◽  
pp. 2427-2437 ◽  
Author(s):  
Rasool Haddadi ◽  
Shahla Eyvari-Brooshghalan ◽  
Alireza Mohajjel Nayebi ◽  
Mohammadmahdi Sabahi ◽  
Sara Ami Ahmadi

Sign in / Sign up

Export Citation Format

Share Document